BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 14870912)

  • 21. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
    Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
    Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome.
    Kapitany A; Tarr T; Gyetvai A; Szodoray P; Tumpek J; Poor G; Szegedi G; Sipka S; Kiss E
    Ann N Y Acad Sci; 2009 Sep; 1173():545-51. PubMed ID: 19758197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM; Kiss MH; D'Amico EA; Silva CA
    Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
    Tincani A; Andreoli L; Chighizola C; Meroni PL
    Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.
    Hachulla E; Michon-Pasturel U; Leys D; Pruvo JP; Queyrel V; Masy E; Arvieux J; Caron C; Brevet-Coupé F; Hatron PY; Devulder B
    Lupus; 1998; 7(2):124-31. PubMed ID: 9541097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinico-immunological aspects of antiphospholipid syndrome].
    Reshetniak TM; Alekberova ZS; Aleksandrova EN
    Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
    Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
    Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome.
    Abraham Simón J; Rojas-Serrano J; Cabiedes J; Alcocer-Varela J
    Lupus; 2004; 13(3):177-81. PubMed ID: 15119546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, systemic lupus erythematosus and monoclonal gammopathies.
    Krause I; Cohen J; Blank M; Bakimer R; Cartman A; Hohmann A; Valesini G; Asherson RA; Khamashta MA; Hughes GR
    Lupus; 1992 Feb; 1(2):91-6. PubMed ID: 1301969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.